Christopher J Corrigan
Overview
Explore the profile of Christopher J Corrigan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1844
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stavraka C, Chauhan J, Crescioli S, McSweeney S, Pope A, Gillett C, et al.
Allergy
. 2025 Mar;
PMID: 40045925
Background: IgE antibodies directed against cancer antigens have demonstrated potent anti-tumour effects in pre-clinical studies. MOv18 IgE, the first-in-class IgE recognising the cancer antigen folate receptor alpha (FRα), showed preliminary...
2.
Spicer J, Basu B, Montes A, Banerji U, Kristeleit R, Miller R, et al.
Nat Commun
. 2023 Jul;
14(1):4180.
PMID: 37491373
All antibodies approved for cancer therapy are monoclonal IgGs but the biology of IgE, supported by comparative preclinical data, offers the potential for enhanced effector cell potency. Here we report...
3.
Harries T, Gilworth G, Corrigan C, Murphy P, Hart N, Thomas M, et al.
BMJ Open Respir Res
. 2022 Aug;
9(1).
PMID: 36041773
Background: Inhaled corticosteroids (ICS) are frequently prescribed outside guidelines to patients with chronic obstructive pulmonary disease (COPD) with mild/moderate airflow limitation and low exacerbation risk. This primary care trial explored...
4.
Yarova P, Huang P, Schepelmann M, Bruce R, Ecker R, Nica R, et al.
J Pharmacol Exp Ther
. 2020 Oct;
376(1):51-63.
PMID: 33115824
Asthma is still an incurable disease, and there is a recognized need for novel small-molecule therapies for people with asthma, especially those poorly controlled by current treatments. We previously demonstrated...
5.
Bax H, Chauhan J, Stavraka C, Khiabany A, Nakamura M, Pellizzari G, et al.
Cells
. 2020 Jul;
9(7).
PMID: 32645919
Basophils are involved in manifestations of hypersensitivity, however, the current understanding of their propensity for activation and their prognostic value in cancer patients remains unclear. As in healthy and atopic...
6.
Bax H, Khiabany A, Stavraka C, Pellizzari G, Chan Wah Hak C, Robinson A, et al.
Allergy
. 2020 Feb;
75(8):2069-2073.
PMID: 32086828
No abstract available.
7.
Harries T, Gilworth G, Corrigan C, Murphy P, Hart N, Thomas M, et al.
Int J Chron Obstruct Pulmon Dis
. 2020 Feb;
14:3063-3066.
PMID: 32021138
COPD patients prescribed inhaled corticosteroids (ICS) outside guidelines should be targeted for ICS withdrawal. Within a primary care population of 209,618 we used a combination of digital search algorithm, individual...
8.
Harries T, Rowland V, Corrigan C, Marshall I, McDonnell L, Prasad V, et al.
Respir Res
. 2020 Jan;
21(1):3.
PMID: 31900184
Background: Blood eosinophil count has been proposed as a predictor of response to inhaled corticosteroid (ICS) in the prevention of acute exacerbations of COPD. An optimal threshold of blood eosinophil...
9.
Frew A, Ljorring C, Wolf H, Wustenberg E, Durham S, Corrigan C, et al.
J Allergy Clin Immunol
. 2018 Aug;
142(6):1998-1999.e3.
PMID: 30149039
No abstract available.
10.
DuBuske L, Frew A, Horak F, Keith P, Corrigan C, Aberer W, et al.
Allergy Asthma Proc
. 2017 Nov;
32(6):466.
PMID: 29165203
No abstract available.